Issues in SMA clinical trial design

This publication has 31 references indexed in Scilit:

• The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophy
  Neuromuscular Disorders, 2006
• La mesure de fonction motrice, outil d’évaluation clinique des maladies neuromusculaires. Étude de validation
  Revue Neurologique, 2006
• Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study
  Neuromuscular Disorders, 2006
• The Utility of Futility
  Stroke, 2005
• Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function
  Annals of Neurology, 2005
• Concerns about the design of clinical trials for spinal muscular atrophy
  Neuromuscular Disorders, 2004
• A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
  New England Journal of Medicine, 1994
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989